3,4-Diaminopyridine in the treatment of congenital (hereditary) myasthenia.

Congenital or hereditary myasthenia describes a heterogeneous group of disorders in which the immune system is not implicated. Treatment has previously depended on anticholinesterase medication. The effectiveness of 3,4-diaminopyridine (3,4-DAP), a preparation that enhances acetylcholine release fro...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Palace, J, Wiles, C M, Newsom-Davis, J
Materialtyp: Artigo
Språk:Inglês
Publicerad: 1991
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC1014681/
https://ncbi.nlm.nih.gov/pubmed/1783919
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk